Director of Sarepta Therapeutics, Inc. (NASDAQ:SRPT), Bonney Michael W, buys 2,000 shares worth $173,480

According to Sarepta Therapeutics, Inc.'s most recent Form 4 filing with the SEC dated Sep 09 02:18 PM, company Director, Bonney Michael W disclosed buying 2,000 shares at a cost of $86.74. At the time of this transaction (Sep 09), this trade was worth $173,480 in total. As of Sep 09, Bonney Michael W now owns 7,051 shares in total worth about $610,898.64.

For the last few recent trades made by Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Director, Bonney Michael W, we have the following information:

    Posted by on Monday September 09 2019, 6:23 PM EDT. All trademarks acknowledged. Filed under Business, Stocks. Comments closed, Trackbacks open. Follow responses: RSS 2.0

    Comments are closed

    News Categories

    Featured Press Releases

    Log in